Biomarker testing patterns among patients newly diagnosed with metastatic non-small cell lung cancer, prostate cancer, and bladder cancer

2026-06-27

0

OA

AI

S

Siraje Mahmud

L

Lisa Dwyer Orr *

M

Mika Cline

A

Ayda Mirsalehi

M

Monica Lisi

L

Laura Ensley

L

Lorraine Brisbin

R

R Steven Paulson

DOI：10.1093/oncolo/oyag243

Original request for help

Save

Abstract

En 中文

National clinical guidelines recommend biomarker testing to identify actionable alterations across cancers, supporting personalized treatment.